Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NITROFURAZONE Cause Rheumatoid factor positive? 84 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Rheumatoid factor positive have been filed in association with NITROFURAZONE. This represents 27.4% of all adverse event reports for NITROFURAZONE.

84
Reports of Rheumatoid factor positive with NITROFURAZONE
27.4%
of all NITROFURAZONE reports
84
Deaths
19
Hospitalizations

How Dangerous Is Rheumatoid factor positive From NITROFURAZONE?

Of the 84 reports, 84 (100.0%) resulted in death, 19 (22.6%) required hospitalization, and 18 (21.4%) were considered life-threatening.

Is Rheumatoid factor positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NITROFURAZONE. However, 84 reports have been filed with the FAERS database.

What Other Side Effects Does NITROFURAZONE Cause?

Type 2 diabetes mellitus (162) Vomiting (152) Weight increased (145) Osteoarthritis (144) Urticaria (144) Hypertension (141) Hypoaesthesia (138) Infusion related reaction (134) Prescribed underdose (132) Nasopharyngitis (129)

What Other Drugs Cause Rheumatoid factor positive?

METHOTREXATE (4,237) TOCILIZUMAB (4,065) ABATACEPT (4,041) ADALIMUMAB (4,020) LEFLUNOMIDE (3,865) RITUXIMAB (3,793) HYDROXYCHLOROQUINE (3,791) INFLIXIMAB (3,584) ETANERCEPT (3,568) SULFASALAZINE (3,306)

Which NITROFURAZONE Alternatives Have Lower Rheumatoid factor positive Risk?

NITROFURAZONE vs NITROGLYCERIN NITROFURAZONE vs NITROUS NITROFURAZONE vs NITROUS\OXYGEN NITROFURAZONE vs NIVOLUMAB NITROFURAZONE vs NIVOLUMAB\RELATLIMAB-RMBW

Related Pages

NITROFURAZONE Full Profile All Rheumatoid factor positive Reports All Drugs Causing Rheumatoid factor positive NITROFURAZONE Demographics